Analysis of the Risk Factors for the Neutropenic Fever in the High Risk NHL Patients for Developing Febrile Neutropenia Who Received 3-weekly CHOP-like Chemotherapy With Primary G-CSF Prophylaxis; Prospective Multicenter Observation Study
Clinical trial NCT01763398 · COMPLETED
Trial details
- NCT number
- NCT01763398
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-09-01
- Primary completion
- 2015-08-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.